Baihe Health Combines AI and Traditional Chinese Medicine for Non-Surgical, Full-Course Breast Health Management

“The Pink Report on Chinese Women’s Health (2023 Edition)” shows that among female users who underwent breast ultrasound examinations, the detection rate of breast nodules (including various types such as solid and cystic breast nodules) was as high as 33.94%, making it a major health concern for contemporary women.

Currently, the prevailing clinical treatment for breast nodules is predominantly surgical resection based on Western medicine, which is associated with challenges such as incomplete eradication, high recurrence rates, and significant surgical trauma. Furthermore, apart from surgical intervention, there is a lack of standardized and unified scientific management protocols for breast nodules, leading many affected women to opt for "complete surgical removal" as their primary treatment approach.

Recognizing this pain point, Beijing Baihe Health Technology Co., Ltd. (hereinafter referred to as “Baihe Health”) chose to enter the market,Dedicated to unlocking the potential of Traditional Chinese Medicine (TCM) therapies in breast health management, we have developed a precision breast care solution based on AI-driven TCM syndrome differentiation.

“Compared with surgical resection in Western medicine, Traditional Chinese Medicine (TCM) focuses on analyzing the pathogenesis and pathology of breast nodules, identifying and addressing the root cause of the disease to achieve treatment of both the manifestations and the underlying cause. This is its most significant advantage,” introduced Wang Ziling, Founder and CEO of Baihe Health.

Founder and CEO of Baihe HealthWang ZilingHolding a master’s degree in computational mathematics from Shanghai Jiao Tong University, Wang Ziling has previously served as a senior data scientist, senior model expert, and senior risk control expert at renowned domestic and international internet companies, including the Japanese firm MTI (with approximately 12 million female members), Renren Inc., and Didi Chuxing. Discussing her motivation for entering the field of precision management for women’s breast health, Wang Ziling stated that it stemmed from her personal experience of being diagnosed with BI-RADS category 3 breast nodules over two years ago.

“At the time, my doctor recommended surgery, but I did not agree immediately. After reviewing extensive information on breast nodules, I learned that Traditional Chinese Medicine (TCM) treatments might be effective,” Wang Ziling explained. She found that after undergoing TCM conditioning with herbal medicine, her breast pain and discomfort were significantly alleviated, and follow-up examinations revealed that the nodules had reversed and disappeared. Through this medical journey, Wang Ziling realized that although the incidence of breast nodules among women is high, there are essentially no unified or effective intervention measures; surgical excision or regular monitoring have become virtually “mandatory options” among the limited treatment approaches. This insight revealed to her the substantial market potential for treating breast nodules through TCM conditioning methods.

At that time, the intense “involution” within major internet companies was at its peak. Wang Ziling recognized the pointless psychological toll of this rat race, which left individuals physically and mentally exhausted, and gradually developed the desire to “escape big tech,” sparking her entrepreneurial ambitions. She aimed to leverage her decade-plus of expertise in big data and algorithms within the internet sector to enhance the diagnostic and treatment efficiency as well as disease management for breast nodules, helping more women overcome the myriad challenges posed by illness and surgery, thereby improving their quality of life. Thus, Baihe Health was established. Meanwhile, the company has attracted numerous talented professionals with significant achievements in traditional Chinese medicine, Chinese herbal medicine, medical imaging, and artificial intelligence.

Baihe Health Founder, Wang Ziling

Co-founder and Chief Product Officer, Zhou LidongA researcher at the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, with over thirty years of experience in natural product chemistry research. Wang Xudong, Co-Founder and Chief Health Advisor, is an Associate Chief Physician at Nanjing Drum Tower Hospital. He graduated from Beijing Medical University (now Peking University Health Science Center) and has nearly three decades of frontline clinical experience. Furthermore, Baihe Health’s advisory team comprises a distinguished group of experts, including directors of gynecology and breast surgery departments at multiple Grade A tertiary hospitals, AI medical imaging specialists from the Institute of Computing Technology of the Chinese Academy of Sciences, members of the Chinese Anti-Cancer Association’s Breast Cancer Professional Committee, and professors from the College of Pharmaceutical Sciences at Zhejiang Normal University.

Baihe Health is people-centric, grounded in the classical Traditional Chinese Medicine (TCM) principle from The Yellow Emperor’s Inner Canon that “superior physicians treat disease before it arises.” It has established a closed-loop management system based on TCM syndrome differentiation, with its core focus on a series of medicine-food homology products jointly developed by Baihe Health and Peigen Bencao that help unblock meridians. This system is supported by a multi-category portfolio of conditioning products and integrates multidisciplinary expertise from Western medicine, health science, nutrition, and psychology. Leveraging AI technology, Baihe Health has created a leading domestic “six-in-one” digital health management service platform for suboptimal breast health, helping women improve breast health and prevent breast cancer.

Unlike Western medicine, Traditional Chinese Medicine (TCM) places greater emphasis on individual differences and the root causes of disease. Through diagnostic methods such as inspection, auscultation and olfaction, inquiry, and pulse palpation, TCM can accurately identify the underlying issues of patients and formulate targeted treatment plans.

“However, public awareness of the role of Traditional Chinese Medicine (TCM) in breast health management remains relatively low. While some TCM clinics currently offer related treatment and management services, the market is uneven in quality and lacks systematic approaches. Furthermore, certain online health management platforms face challenges such as the inability to conduct breast cancer screening, low patient compliance, and failure to establish a closed-loop diagnosis and treatment system,” introduced Wang Ziling. Baihe Health has positioned itself precisely, focusing on women’s breast health since its inception. It has developed a precision conditioning solution for breast health based on AI-driven TCM syndrome differentiation, securing a significant first-mover advantage. Central to this approach is its AI-based automatic TCM syndrome differentiation and classification technology for breast conditions, which serves as the core foundation for the company’s product development and the implementation of personalized diagnosis and treatment.

According to the TCM dialectical theory for breast diseases, breast nodules are classified into four major syndromes: liver qi stagnation, disharmony of the Chong and Ren meridians, qi stagnation with phlegm coagulation, and deficiency of the spleen and kidney. Baihe Health, in collaboration with Anhui University of Chinese Medicine and Yunzhen Technology, has developed an AI-based TCM syndrome differentiation and classification technology for breast conditions. This technology integrates the aforementioned TCM syndromes with pathological manifestations, grounded in the TCM therapeutic principle of “personalized prescriptions for individual patients.”

Based on a multi-scale convolutional neural network for localized quantitative analysis of tongue images, this technology has been trained on over 4 million tongue image cases. It can generate corresponding assessment reports within seconds after patients upload their tongue images, achieving an accuracy rate of 98%.Meanwhile, this technology achieves sufficient precision in localizing breast diseases, significantly improving efficiency compared to traditional consultation models and providing a basis for personalized, precise health management.

Specifically, the system first collects and inputs patient-related information and simulates expert judgment to intelligently classify conditions into three severity levels: mild, moderate, and severe. Subsequently, patients upload tongue photographs, enabling the system to perform tongue image analysis across approximately 40 characteristic features, including tongue color, coating color, tongue shape, coating texture, moisture, and sublingual veins. Meanwhile, the system accurately identifies the patient’s health status, covering 10 single constitutions, 28 composite constitutions, and 65 common Traditional Chinese Medicine (TCM) syndromes. Based on this data, the system categorizes patients into four major TCM syndrome differentiation types for breast conditions, conducts a comprehensive assessment by integrating disease-inducing factors from the patient’s lifestyle habits, and ultimately provides holistic, personalized regimen solutions.

In terms of products, Baihe Health has developed differentiated oral and topical formulations based on four major syndrome patterns.

Baihe Health’s line of oral conditioning products is developed by the Peigen Bencao team, which specializes in medicinal plant research. These products are pure natural extracts formulated as dual-purpose food and herbal remedies for breast health. Scientifically compounded based on traditional Chinese medicine formulas, they are custom-developed according to four major syndrome types, achieving a “one formula per syndrome type” approach.

Medicinal and Edible Homology Wellness Product - Lizhe Yin

In the realm of topical physiotherapy products, Baihe Health conducts product research and development based on the Feng’s Enzyme Formula Topical Patch technology. This technology processes proprietary formula components through a bio-enzymatic fermentation process, utilizes transdermal drug delivery techniques to help elevate body temperature, and provides differentiated stimulation of meridian acupoint combinations tailored to patients’ specific syndrome patterns.

Overall,In the realm of breast health management, Baihe Health has established an AI-driven "six-in-one" digital closed-loop management model,The solution encompasses six key components: intelligent health education, intelligent self-assessment, intelligent screening, AI-based tongue diagnosis and syndrome differentiation, a matrix of conditioning products, and intelligent follow-up. Currently, this program can be conducted entirely online, with dedicated personnel providing guidance. “Breast health management is a chronic issue that requires gradual conditioning. We set personalized, phased management goals for each patient and provide continuous follow-up and guidance to improve patient adherence,” introduced Wang Ziling.

“Manman” APP Platform

Currently, Baihe Health’s breast care service package has been launched on the company’s proprietary “Manman” app platform, offering a comprehensive “2+3+1” breast care service. The “2” refers to traditional Chinese medicine (TCM) products for internal administration and external application; the “3” denotes lifestyle interventions targeting sleep, diet, and psychological well-being, in addition to syndrome differentiation and typing enabled by AI-driven TCM breast diagnosis technology, thereby helping patients cultivate healthy habits; and the “1” signifies dedicated guidance consultants. The service begins with intelligent robot consultations and regular communication feedback. For more in-depth and complex issues, professional TCM health specialists from Baihe Health provide one-on-one guidance. For personalized underlying factors such as sleep disturbances and psychological concerns, chief TCM physicians deliver targeted improvement and treatment.

APP Breast Management Page

Regarding the future, Wang Ziling stated that in the short term, the company will primarily focus on expanding the scale of its online services, aiming to reach a user base in the millions, while gradually expanding its offline clinics to provide better comprehensive services for patients with in-depth conditioning needs. In the long run, Baihe Health hopes to expand its focus from breast health to a broader range of women's health issues, providing full-lifecycle health management services for women to help them live healthier and more confident lives.